PURIFICATION AND CHARACTERIZATION OF KYNURENINE AMINOTRANSFERASE-I FROM HUMAN BRAIN

Citation
H. Baran et al., PURIFICATION AND CHARACTERIZATION OF KYNURENINE AMINOTRANSFERASE-I FROM HUMAN BRAIN, Journal of neurochemistry, 62(2), 1994, pp. 730-738
Citations number
49
Categorie Soggetti
Biology,Neurosciences
Journal title
ISSN journal
00223042
Volume
62
Issue
2
Year of publication
1994
Pages
730 - 738
Database
ISI
SICI code
0022-3042(1994)62:2<730:PACOKA>2.0.ZU;2-H
Abstract
Two kynurenine aminotransferases (KATs), arbitrarily termed KAT I and KAT II, are capable of producing the neuroinhibitory brain metabolite kynurenic acid from L-kynurenine in human brain tissue. Here we descri be the purification of KAT I to homogeneity and the subsequent charact erization of the enzyme using physicochemical, biochemical, and immuno logical methods. KAT I was purified from human brain similar to 2,000- fold with a yield of 2%. Assessed by polyacrylamide gel electrophoresi s, KAT I migrated toward the anode as a single protein with a mobility of 0.5. The pure enzyme was found to be a dimer consisting of two ide ntical subunits of similar to 60 kDa. Among several oxo acids tested, KAT I showed highest activity with 2-oxoisocaproate. Kinetic analyses of the pure enzyme revealed an absolute K-m of 2.0 mM and 10.0 mM for L-kynurenine and pyruvate, respectively. KAT I activity was substantia lly inhibited by L-glutamine, L-phenylalanine, and L-tryptophan, using either pyruvate (1 mM) or 2-oxoisocaproate (1 mM) as a cosubstrate. L -Tryptophan inhibited enzyme activity noncompetitively with regard to pyruvate (K-i = 480 mu M) and competitively with regard to L-kynurenin e (K-i = 200 mu M). Anti-KAT I antibodies were produced against pure K AT I and were partially purified by conventional techniques. Immunotit ration and immunoblotting analyses confirmed that KAT I is clearly dis tinct from both human KAT II and rat kynurenine-pyruvate aminotransfer ase. Pure human KAT I and its antibody will serve as valuable tools in future studies of kynurenic acid production in the human brain under physiological and pathological conditions.